Trademarkia Logo

Canada

C$
ABIVAX
SEARCHED

on 7 Sept 2023

Last Applicant/ Owned by

ABIVAX

7-11 Boulevard HaussmannF-75009 Paris

FR

Serial Number

2228247 filed on 31st Oct 2022

Correspondent Address

ANTONIO TURCO

(CPST Intellectual Property Inc.)130 Queens Quay EastEast Tower, Suite 809Toronto,

ONTARIO

CA

M5A0P6

ABIVAX

Trademark usage description

pharmaceutical preparations for the prevention and treatment of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, musculoskeletal, viral, and fungal disease and other related diseases; vaccines for human and veterinary use; adjuvants for use with vaccines.


Classification kind code

11

Class [042]
Pharmaceutical research and development; drug development and discovery services; medical and scientific research; providing medical and scientific research information services; research services in the field of pharmaceuticals; laboratory research services relating to pharmaceuticals.


Classification kind code

11

Mark Details


Serial Number

2228247

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 256
on 16th Oct 2023
Notification of Possible Opposition Sent
Submitted for opposition 48
on 19th Sept 2023
Agent Changed
Submitted for opposition 22
on 7th Sept 2023
Search Recorded
Submitted for opposition 20
on 7th Sept 2023
Examiner's First Report
Submitted for opposition 223
on 7th Sept 2023
Total Provisional Refusal
Submitted for opposition 257
on 15th Dec 2022
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 14th Dec 2022
Formalized
Submitted for opposition 1
on 14th Dec 2022
Created
Submitted for opposition 228
on 31st Oct 2022
International Registration
Submitted for opposition 30
on 31st Oct 2022
Filed